The Code sets standards for the promotion of medicines to health professionals and other relevant decision makers in the UK. It includes requirements for the provision of information to patients and the public and relationships with patient groups. The Code also applies to a number of areas that are non-promotional.
During the period 1 January to 30 April 2016 no material or activity will be regarded as being in breach of the Code if it fails to comply with its provisions only because of requirements which the 2016 Code introduces.
The Code covers:
The detailed provisions in the Code aim to ensure that pharmaceutical companies operate in a responsible, ethical and professional manner.